The number of Americans taking cutting-edge weight-loss drugs like Ozempic, Wegovy and Zepbound has skyrocketed in recent ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

GLP-1 receptor agonists are synthetic drugs that mimic ... While GLP-1 drugs are popular for helping users lose weight quickly, they can also have an unfortunate side effect: muscle loss.

and GLP-1 agonists such as semaglutide (in people with both HFpEF and obesity). These drugs help people lose weight and have ...

Whether it’s plant-based, high-protein, or now GLP-1-conscious, food should be part of the solution, not the problem,” Matias Muchnick, NotCo founder and CEO, told The Post. What is a GLP booster? GLP ...

SAN DIEGO — Results presented here showed patients who had significant weight loss prior to total hip arthroplasty with use of a GLP-1 receptor agonist experienced a decreased risk for ...

The startup claims that, unlike injectable drugs such as Ozempic and Mounjaro, which can have side effects, its solution is a ...

Kennedy Jr., who was tapped to lead the Department of Health and Human Services for the Trump administration, recently ...

and GLP-1 agonists such as semaglutide (in people with both HFpEF and obesity). These drugs help people lose weight and have also been shown to reduce hospitalization for heart failure.

Eli Lilly has already got a GIP, GLP-1 and glucagon agonist into late-stage development in the form of retatrutide, which was tied to a 16% weight loss at 24 weeks in a phase 2 study in 2023.

and GLP-1 agonists such as semaglutide (in people with both HFpEF and obesity). These drugs help people lose weight and have also been shown to reduce hospitalization for heart failure.